Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
David M. Holtzman, Joachim Herz, Guojun Bu
Cold Spring Harbor Perspectives in Medicine (2012) Vol. 2, Iss. 3, pp. a006312-a006312
Open Access | Times Cited: 737

Showing 1-25 of 737 citing articles:

2016 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2016) Vol. 12, Iss. 4, pp. 459-509
Closed Access | Times Cited: 4978
2019 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2019) Vol. 15, Iss. 3, pp. 321-387
Closed Access | Times Cited: 2173
2020 Alzheimer's disease facts and figures
In this phase, individuals have measurable brain changes that indicate the earliest signs of Alzheimer's disease, but they have not yet developed symptoms such as memory loss. Examples of measurable brain changes …, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 3, pp. 391-460
Open Access | Times Cited: 2146
2023 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2023) Vol. 19, Iss. 4, pp. 1598-1695
Open Access | Times Cited: 2000
2022 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2022) Vol. 18, Iss. 4, pp. 700-789
Closed Access | Times Cited: 1989
2021 Alzheimer's disease facts and figures
In the past, was often used to describe the dementia phase of the disease. Today we know that dementia is only …, Adult Disease, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 3, pp. 327-406
Closed Access | Times Cited: 1921
2018 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2018) Vol. 14, Iss. 3, pp. 367-429
Closed Access | Times Cited: 1803
Blood-Brain Barrier: From Physiology to Disease and Back
Melanie D. Sweeney, Zhen Zhao, Axel Montagne, et al.
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 21-78
Open Access | Times Cited: 1670
Microglia in Alzheimer’s disease
David V. Hansen, Jesse E. Hanson, Morgan Sheng
The Journal of Cell Biology (2017) Vol. 217, Iss. 2, pp. 459-472
Open Access | Times Cited: 1566
2015 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2015) Vol. 11, Iss. 3, pp. 332-384
Closed Access | Times Cited: 1548
2017 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2017) Vol. 13, Iss. 4, pp. 325-373
Closed Access | Times Cited: 1269
The Amyloid-β Pathway in Alzheimer’s Disease
Harald Hampel, John Hardy, Kaj Blennow, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 5481-5503
Open Access | Times Cited: 1041
Diagnosis and Management of Dementia: Review
Zoe Arvanitakis, Raj C. Shah, David A. Bennett
JAMA (2019) Vol. 322, Iss. 16, pp. 1589-1589
Open Access | Times Cited: 1018
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Yang Shi, Kaoru Yamada, Shane A. Liddelow, et al.
Nature (2017) Vol. 549, Iss. 7673, pp. 523-527
Open Access | Times Cited: 1010
TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
Felix L. Yeh, Yuanyuan Wang, Irene Tom, et al.
Neuron (2016) Vol. 91, Iss. 2, pp. 328-340
Open Access | Times Cited: 765
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
Robert W. Mahley
Journal of Molecular Medicine (2016) Vol. 94, Iss. 7, pp. 739-746
Open Access | Times Cited: 734
Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Axel Montagne, Zhen Zhao, Berislav V. Zloković
The Journal of Experimental Medicine (2017) Vol. 214, Iss. 11, pp. 3151-3169
Open Access | Times Cited: 572
Age, APOE and sex: Triad of risk of Alzheimer’s disease
Brandalyn C. Riedel, Paul M. Thompson, Roberta Dı́az Brinton
The Journal of Steroid Biochemistry and Molecular Biology (2016) Vol. 160, pp. 134-147
Open Access | Times Cited: 525
Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
Colin L. Masters, D. J. Selkoe
Cold Spring Harbor Perspectives in Medicine (2012) Vol. 2, Iss. 6, pp. a006262-a006262
Open Access | Times Cited: 503
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight
Yang Shi, David M. Holtzman
Nature reviews. Immunology (2018) Vol. 18, Iss. 12, pp. 759-772
Open Access | Times Cited: 502
Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease
Weiguo Peng, Thiyagarajan M. Achariyar, Baoman Li, et al.
Neurobiology of Disease (2016) Vol. 93, pp. 215-225
Open Access | Times Cited: 484
ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion
Yu‐Wen Alvin Huang, Bo Zhou, Marius Wernig, et al.
Cell (2017) Vol. 168, Iss. 3, pp. 427-441.e21
Open Access | Times Cited: 453
Alzheimer’s Disease Genetics: From the Bench to the Clinic
Celeste M. Karch, Carlos Cruchaga, Alison Goate
Neuron (2014) Vol. 83, Iss. 1, pp. 11-26
Open Access | Times Cited: 442
Central Nervous System Lipoproteins
Robert W. Mahley
Arteriosclerosis Thrombosis and Vascular Biology (2016) Vol. 36, Iss. 7, pp. 1305-1315
Open Access | Times Cited: 398
TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
Cheryl E. G. Leyns, Jason D. Ulrich, Mary Beth Finn, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 43, pp. 11524-11529
Open Access | Times Cited: 386
Page 1 - Next Page

Scroll to top